Viewing Study NCT03670069


Ignite Creation Date: 2025-12-24 @ 10:46 PM
Ignite Modification Date: 2026-02-19 @ 5:13 PM
Study NCT ID: NCT03670069
Status: TERMINATED
Last Update Posted: 2024-05-08
First Post: 2018-09-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Itacitinib in Treating Patients With Refractory Metastatic/Advanced Sarcomas
Sponsor: Fred Hutchinson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module